精密科學

104.95
Open
104.91
Market Cap
20.03B+
High
104.91
Low
104.91
Close
104.91
Volume
0.00
P/E Ratio
-95.37
Div/Yield
0.00%

About 精密科學

Exact Sciences Corporation 在美國和國際上提供癌症篩查和診斷測試產品。該公司提供 Cologuard,一種基於糞便的非侵入性 DNA 篩查測試,用於檢測與結直腸癌和癌前病變相關的 DNA 和血紅蛋白生物標誌物。它還提供 Oncotype DX,一種針對乳腺癌、前列腺癌和結腸癌的基因表達測試; Oncotype 測試,一種提供腫瘤分析的組織測試,以幫助晚期、轉移性、難治性或複發性癌症患者選擇治療方法; Oncotype DX AR-V7 Nucleus Detect Test,一種針對晚期前列腺癌的液基檢測; Oncomap ExTra,提供某些難治性、罕見性或侵襲性癌症的完整生物學圖像;和 Covid-19 測試服務。該公司的管道產品專注於增強 Cologuard 測試的性能特徵以及開發血液和其他基於液體的測試。它與梅奧醫學教育和研究基金會有許可協議; Exact Sciences Corporation 成立於 1995 年,總部位於威斯康星州麥迪遜市。

如何購買 精密科學 (EXAS)

登入
1分鐘開戶

1分鐘開戶

僅需1分鐘即可完成帳戶申請和驗證。整個過程完全自助,支援 RockFlow App 和網頁端操作。

充值資金

充值資金

帳戶驗證完成後,您可以使用首選的支付方式向帳戶充值。

購買 EXAS

購買 EXAS

透過 RockFlow App 或網頁端搜尋 EXAS,輸入您想要投資的金額,然後點擊確認即可完成交易。

logo

Social

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.